Thu, Oct 23, 2014, 12:06 PM EDT - U.S. Markets close in 3 hrs 54 mins


% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • dlhild Feb 24, 2010 4:35 PM Flag

    Part 2 - Medafor Fights Back

    Approximately one week ago, Medafor sent a letter to its shareholders disclosing additional information regarding the CryoLife offer including details of the Board of Director’s unanimous rejection of the CryoLife bid.
    “Grossly Inadequate” was the board’s answer to CryoLife’s $2 per share cash and stock bid. To start with, said Medafor’s board, the supply contract with CryoLife is valued between $40 million to $50 million so why accept, in effect, $40 million now? Next, sales to CryoLife account for only 20% of Medafor’s sales, so selling the whole company for $2 per share seems patently ridiculous. Finally, and this is the coup-de-grace, of those sales to CryoLife, Medafor’s own sales organization generated $5.1 million of CryoLife’s reported $6 million in sales. In other words, Medafor’s own sales force accounted for 85% of CryoLife’s reported MPH product sales.
    As of last week, only five of Medafor’s 550 shareholders have accepted CryoLife’s $2/share offer. CryoLife has sent several letters to Medafor’s shareholders and this week repeated its offer on the conference call with analysts. Less than 1% of Medafor’s shareholders have accepted it despite the direct solicitations and implied threats.
    The five shareholders who tendered their shares to CryoLife for $2/share represent 11% of Medafor’s shares outstanding. After reading Medafor’s letter to CryoLife, those five shareholders may want to ask for their shares back.

10.55+0.33(+3.23%)12:04 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.